Neuromodulation by electrical stimulation of the human cervical vagus nerve may be limited by adverse side effects due to stimulation of off-target organs. It may be possible to overcome this by spatially selective stimulation of peripheral nerves. Preliminary studies have shown this is possible using a cylindrical multielectrode nerve cuff optimised for human vagus nerve selective neuromodulation. The design was optimised initially by computer modelling. This suggested two rings of 14 electrodes, 3 mm apart, with 0.4 mm electrode width and separation and length 0.5-3 mm, with stimulation through a pair in the same radial position on the two rings. The electrodes were fabricated using PDMS-embedded stanless steel foil and PEDOT: pTS coating. In the cervical vagus nerve in anesthetised sheep, it was possible to selectively reduce the respiratory rate by 85  5 % without affecting heart rate, or selectively reduce heart rate by 20  7 % without affecting respiratory. The cardiac-and pulmonary-specific sites were localised peripherally with a radial separation of 105  5 degrees and did not intersect (P < 0.01, N = 24, in 12 sheep). This suggests there is organotopic organisation of neural fibres in the cervical vagus nerve. It demonstrates for the first time selective electrical neuromodulation without adverse side effects. It may be possible to translate this to improved treatment by electrical autonomic neuromodulation for currently intractable conditions.
Introduction
In recent years, electrical neuromodulation of peripheral nerves to relieve various conditions has received a dramatic increase in interest in the academic and industrial community [1] [2] [3] . The concept is to place a small cuff device around a nerve to send electrical impulses, generating action potentials which are transmitted to the organ of interest and hence modulate the function of the organ. Such devices are currently used in clinics for management of drug-resistant epilepsy [4] , chronic heart failure [5, 6] , stroke rehabilitation [7] , chronic inflammation [8] , and also other disease models [9] have promising results in animals. Due to the relative ease of surgical access, most of the current peripheral nerve facing devices are implanted in the neck to interface with the cervical vagus, the main autonomic trunk to all organs of the body. However, there is ongoing investigation of their use in smaller peripheral nerves such as sacral [10] or tibial [11] nerves for overactive bladder, peroneal nerve for foot drop [12] , hipoglossal nerve for obstructive sleep apnea [13] , or occipital nerve for chronic pain management [14] .
Although there have been promising results in animal studies, few vagus nerve stimulation devices reach clinical approval Current autonomic nerve stimulators stimulate the nerve bundle indiscriminately. As the vagus nerve innervates numerous organs, including the heart, lungs, intestines, spleen, and larynx, non-targeted neuromodulation of the nerve causes off-target effects, which limits the applicability of such devices. Human vagal nerve stimulators for epilepsy, for example, cause cough, voice alteration, nausea, and pain [15] , which are evoked by activation of pulmonary afferents, recurrent laryngeal efferents, and pain nociception fibres. A study into the effectiveness of treatment for chronic heart failure concluded that effective treatment cannot be delivered without side effects such as dysphonia, cough and stimulationrelated pain. These necessitated reduction of the stimulation intensity but this reduced or eliminating the therapeutic effect [9] .
A potential way of eliminating side effect would be to deliver the current in a spatially selective way, where only the specific part of the nerve containing required nerve fibres is activated. This can be achieved through either current steering with an external cuff device [16, 17] , or penetrating electrode arrays [18, 19] . The latter is currently far away from clinical applications because of concerns regarding their chronic use, as the presence of rigid foreign material in nerves causes tissue damage and an inflammatory response [20, 21] . The application of flexible extra-neural multi-electrode devices to vagus nerve to aid selectivity of recruitment is a viable option, but is still at an early stage. The most recent advances demonstrated blood pressure control without side effects in rats [22] , and selective neuromodulation of cardiac, pulmonary, urinary, and endocrine function in dogs [23] . There are also some preliminary results on selective alteration of heart function in humans [24] . However, those studies used arbitrary electrode geometries and count; electrode arrays were reportedly hard to fabricate, and the latter studies were performed in 2 dogs and 4 humans, respectively, with inconsistent results on efficasy and inconsistent physiological alterations reported.
Hence, there is a clear need for investigation and optimisation of such extra-neural multi-electrode cuff arrays, which can be surgically implanted around the peripheral nerves, such as vagus nerve, and can potentially be used for multiple disease treatments by altering the spatial selectivity of the current to the fascicle of interest.
In terms of the applied stimulation waveform, there are multitude of pulse waves which can be employed to increase efficiency of the neuronal stimulation, ranging from unidirectional square to decaying or raising exponential [22] , [23] . However, most human approved devices use biphasic charge balanced waveform due to the safety reasons [27] and the fact that that generating an implantable pulse generator with such high resolution waveforms is highly energy inefficient and computationally difficult due to the μS resolution requiredThe purpose of this work was to optimise and test the efficiency of a multi-electrode array for use in human-sized vagus nerve while ensuring ability to test physiological outcomes from organs of interest. Questions to be asked were: a) What is the optimal geometry, configuration, and number of electrodes? b) What is the optimal current steering strategy for biphasic symmetric current pulse? c) What is the efficacy of the optimal device tested in in-vivo acute large animal experiments?
Methods

Experimental Design
We have employed a biphasic symmetric square pulse as a reliable standard which is currently being used in implantable stimulators [27] . First, optimisation of the array geometry was performed in simulations. The parameters of fibre activation were set to average mammalian myelinated nerve fibre [28] . A nerve equivalent in size to the human cervical vagus nerve was modelled in 3D with electrodes placed in bilateral adjacent configuration, and using biphasic square current pulse for stimulation. The size and distance between the electrodes varied, and optimal parameters were evaluated to minimise the objective function representing the total area activated in the nerve and current density injected by the electrodes while activating required fascicles (eq. 2). Then, with the aid of computer simulations, it was shown that adjacent bilateral configuration satisfied total optimal conditions in wider range of multi-electrode configurations given the above criteria.
The suggested optimal design was adjusted given real-life manufacturability and impedance considerations and then manufactured and implanted around the cervical vagus nerve in 12 healthy anesthetised sheep. Electrical stimulation was performed using each possible 14 electrode pair in turn while measuring respiratory rate (RR) through end-tidal CO2 (EtCO2), and heart rate (HR) through electrocardiogram (ECG) and arterial blood pressure (ABP). Sites with significant changes in respiratory or cardiac rate were identified. The stimulation current amplitude was then adjusted if necessary with aim of selective activation of one variable without effect on the other.
Optimisation in simulations
A 3D cylindrical model of a human-sized vagus nerve was produced in the COMSOL simulation software. The model was 2.8mm in diameter, and had 2 compartments: intraneural space with fascicles (effective average conductivity 0.3 S/m), and 100μm-thick epineurium (0.083 S/m, [29] ) surrounding the latter (Figure 1a) . Discretisation was performed according to mesh convergence criteria with the smallest electrode sizes, resulting in the optimal mesh to be 5M regular tetrahedral elements refined in the area of electrode application. The electrodes were placed with application of a complete electrode model [30] on elements occupying relevant areas of the outer surface of the model in order to simulate effects of the current redistribution due to a contact impedance. Two radially located "virtual fascicles" were placed beneath the electrodes, one 1/3 and another 2/3 of the radius towards the nerve centre, to serve as a target for neuronal stimulation. The simulations were performed for each set of parameters (Table 1 ), supplying unit current between the electrodes and evaluating the voltage distribution in the volume . Then the activating functions were extracted in the fascicle locations [31] :
where was the longitudinal direction parallel to the axon, and ( 0 , 0 ) werre the cross-sectional coordinates of the fibre. Next the threshold of activation, given the shape of the activating function, was determined for each case linear search on the amplitude of the activating function, which was supplied as a boundary condition for the model of myelinated axon. An accurate 1D FEM double-cable model of a mammalian sensory fibre was developed. It contained ten ion channels taken from an experimentally validated spaceclamped model [32] : four at the node and six at the internode. A realistic morphology of the fibre [33] was implemented similarly to the one used in [34] . To match the experimental data, several geometrical (Appendix 1. Table 3 ) and electrical (Appendix 1. Table 4 ) parameters were changed in the new FEM model. With these changes, the conduction velocity of the fibre and the shape of membrane potential at the nodes and internodes in resting state and during excitation, matched an experimentally validated space-clamped model [32] . The complete description and validation of the model is described in the [35] .
After the threshold of activation was established, the threshold current needed for activating the fibre was recalculated for each parameter . Then total activated area in the cross-section (above the activation threshold) (‖ ( )‖ > ), and maximum current density directly beneath the electrodes were calculated. The normalised sum was computed as an objective function, and minimised over the parameters:
Before considering more complex geometrical arrangements, a symmetrical longitudinal bipolar configuration was optimised by varying electrode width, length, and distance between the electrodes. Then it was shown that a bipolar configuration produced at least a local minimum of the objective function over all possible extended geometrical arrangements, and hence completed the optimisation process for 2-electrode arrangement. Here, given the symmetry of the problem, one of the electrodes was fixed with its optimal parameters, while the other was changed: The width and length of the electrode, as well as its radial and longitudinal location were increased from half of the optimum to the double. The derivative of the objective cost function was computed along each parameter, and the global positivity of the derivative indicated that the starting configuration is indeed minimal.
The principle of the minimisation of the sum for convex functions [36] allows therefore extending the proof of optimum to span all possible multiple-electrode configurations. Thus the global optimum among all possible configurations was achieved, given the constraints of biphasic square wave pulse which delivered with bipolar balanced current source. To illustrate this point, the cost function was computed for several examples previously used in literature: 2-electrode cross-sectional adjacent.
Selected optimal parameters were then slightly adjusted given the practicality of the manufacturing and in-vivo experimental requirements (mainly laser cutting accuracy, PDMS stiffness, and real-life contact impedance after PEDOT: pTS coating), and optimal designs were produced as described in the next section. 
Electrode array fabrication
Optimal electrodes were fabricated using a laser cutting stainless steel-on-silicone rubber approach. Connecting tracks were 150 µm wide with an inter-track spacing of 35 µm. The total thickness of the array was 220 to 250 µm. After fabrication, electrodes were coated with PEDOT:pTS to reduce contact impedance below 1kOhm at 10 Hz for each electrode [37] .
The following protocol was used ( Figure 2 ): 1) A 10 μm release layer (Poly(4-Styrenesulfonic Acid), Sigma Aldrich, UK) was spin-coated on the 70x40 mm glass slides (Fisher Scientific, UK) followed by approximately 100 μm layer of the silicone rubber (MED4-4220, Polymer Systems Technology Ltd, US). 2) The silicone was cured for 5 mins at 100 C in the oven. 3) Stainless steel foil (0.0125 mm, Advent Research Materials, UK) was glued on top of the rubber. 4)
The electrode profile was cut using a 20W precision laser cutter (355 nm, IDG lab, UCL, UK). 5) Excess foil was peeled off, and the second 100 μm layer of the silicone rubber spincoated on top. 6) The electrode openings and connector pads were laser-cut and peeled away. 7) Finally, the array was glued on the inside of the 3mm ID silicone rubber tube (SigmaAldrich, UK) with thread mounted to assist implantation, and connector side was attached to a custom PCB using three 20-way 1.5 mm connectors (Farnell, UK). The complete fabrication process, together with the evaluation of the electrode performance can be found in [37] . Figure 2 . Electrode fabrication procedure. a) The stainless steel foil is attached to a PDMS substrate, lasercutt, coated with second layer of PDMS and patterned following electrode sites opening. b) Electrode sites are coated with PEDOT:pTS. c) The cuff is formed into the tubular configuration by either using existing PDMS tube, or glued to a sandwiched pre-stressed PDMS sheets.
In-vivo experiments
Anaesthesia and
Maintenance. 12 sheep were anaesthetised by induction using ketamine (5 mg/kg) and midazolam (0.5 mg/kg) injected IV into the jugular vein. A tracheal tube was then inserted into the trachea for the primary purpose of establishing and maintaining a patent airway and to maintain general anaesthesia using sevoflurane carried in an oxygen/air mixture. After induction of general anaesthesia, the animal was positioned in dorsal recumbency. Indwelling catheters were percutaneously placed in both the external jugular veins and one in the femoral artery (for blood pressure and blood gas monitoring) using ultrasonographic guidance. An intra-oesophageal tube was inserted to drain refluxes from the rumen. The animal was instrumented with ECG leads and pulse oximeter. A spirometer was connected to the tracheal tube. An intranasal probe was used to control temperature.
Surgery.
The palpebral and corneal reflexes, medioventral eye ball position, and jaw tone were used to monitor anaesthetic depth prior to surgery initiation. Nystagmus as well as lacrimation were monitored as possible signs of a light plane of anaesthesia. The animal was mechanically ventilated using pressure control mode for the duration of the surgery and implantation, after which the animal was kept on spontaneous ventilation during the stimulation sessions. Animals were placed onto mechanical ventilation between rounds of stimulations if required to restore normal levels of CO2 (between 35-45 mmHg). Body temperature was maintained using a hot air warming system if necessary. Ringer lactate fluid therapy at a rate of 5 ml/kg/h was administered intravenously throughout the procedure. Glucose was administered at discretion of the anaesthetist when blood glucose was lower than 4 mmol/L.
Monitoring and recordings.
Arterial blood gases were analysed using a blood gas machine (i-stat, Abbott, USA) throughout the experiment to monitor pH, Glucose, PaO2, PaCO2, Bicarbonate, SaO2, Na + , Cl -, Ca 2+ and K + levels. All physiological parameters (including heart rate, systemic arterial blood pressure, central venous pressure) as well as the level of delivered sevoflurane were recorded. Depth of anaesthesia throughout the experiment was assessed by inspecting physiological parameters as well as using a bispectral index monitoring system (BisTM, Medtronic, USA). Levels of sevoflurane were adjusted accordingly by the anaesthetist. In some cases, boluses of propofol or fentanyl were used if required and noted on the records. Physiological data were outputted from the anesthesia monitor (Aestiva 5, General Electric, Finland) into a 16-channel Powerlab system. Raw ECG, systemic arterial blood pressure (sABP), end-tidal CO2, % of expired Sevoflurane, and central venous pressure were digitalised by a Powerlab acquisition system and sampled at 2000 Hz with LabChart 8.0 software (AD Instruments, UK). Calculated channels (for live measurement of HR, systolic ABP, diastolic ABP, mean ABP, respiratory rate) were added in the Labchart as needed. A trigger channel was also used to link the stimulator to the physiological data.
Electrode implantation.
After induction of anaesthesia and placement in dorsal recumbency, the ventral neck region was clipped and aseptically prepared using chlorhexidine-based solutions, prior to placement of sterile drapes, leaving only a small window open for accessing the right cervical vagus nerve. Using aseptic technique, a 20 cm longitudinal skin incision was made using monopolar electrocautery centred immediately to the right of the trachea from the larynx caudad. The incision was continued through the subcutaneous tissue and the sternohyoideus musculature using sharp/blunt technique until encountering the carotid sheath and right vagus nerve. Two segments measuring 3-5 cm each of the right vagus nerve (RVN) were circumferentially isolated by blunt dissection. Artery forceps were then inserted under the nerve from lateral to medial, Figure 3 . The experimental setup for in-vivo evaluation. a) Optimal electrode array was manufactured and b) implanted on the vagus nerve of anaesthetised sheep. Physiological parameters were measured whilst probing the circumferential electrode locations with 30s stimulation followed by 30s intertimulus time.
grasping one pair of suture glued to the custom made cuff electrode array introduced into the surgical field. The cuff was placed around the nerve by pulling on the opposite pair of sutures to open the cuff and carefully slide the vagus inside it. Electrical ground and heart electrodes were inserted into the surgical field. The surgical field was then rinsed with sterile saline, and the skin temporarily closed using towel clamps.
Electric stimulation.
The optimised arrays were placed around the vagus nerve during terminal experiments in 12 healthy sheep (Figure 3) . A protocol of stimulation with the multi-electrode array was generated using MATLAB. Stimulation was delivered to the RVN using one pair of longitudinally paired electrodes at a time. Each stimulation consisted of a period of 30 s of stimulation and 30 s of recovery. Matched longitudinal pairs in the same radial position on both rings were sequentially selected for current application. All the stimulations were performed while sheep was at steady state and the same depth of anaesthesia. Physiological endpoints were measured (EtCO2, ECG, ABP) from which heart rate (HR) and breathing rate (BR) were calculated. During the experiment, current amplitude was adjusted so that physiological effects were observed in 1-3 out of 14 pairs. This resulted in a stimulation amplitude range between 200 and 800 μA across all the animals. The observed responses for each stimulation pair were displayed, evaluated and compared with the baseline (30 sec prior to stimulation). Stimulation was delivered with a square biphasic (positive first) constant current temporal waveform using a balanced current source (Keithley, UK model no 6221, with a PW of 100 μs; 50 μs for each phase and no interphase delay) and at a frequency of 5 or 20 Hz. The frequency of pulses was 20 Hz.
Results
Optimisation in simulations
3.1.1. Bipolar longitudinal configuration. The current density beneath the electrodes exponentially decreased with electrode area (Figure 4.b) . Despite that, however, the total injected current required for fascicle activation did not change exponentially with electrode area (Figure 4 .c). It was 35020 μA for deep, and 16010 uA for superficial fibre with the smallest electrodes (0.05 mm 2 ), compared to 42010 μA, and 20010 for the largest (2 mm 2 ). The influence of the geometry was apparent in the longitudinal shape of activating functions (Figure 4.b,c) . This subsequently altered the threshold of activation, with the most influential parameter being the distance between the electrodes (Figure 4 .e): for shortest electrodes (0.5mm) located close together (0.5mm) it was 9.90.1*10 7 mV/cm 2 which was halved (51*10 7 mV/cm 2 ) when the same electrodes were located 4.5mm apart. Analysis of the objective cost function showed that the electrode length did not alter the function significantly, apart from the very short electrode case (Figure 4 .f, P > 0.5), although the general trend was that deeper fascicle was activated more efficiently with longer electrodes. The most significant parameter for optimisation was the electrode width (Figure 4.d) , which changed the cost function value significantly (P < 0.01) across the range of configurations. Electrodes which were wider than 0.8mm produced a significant artificial drop in cost function: reduction in current density on the electrodes was no longer compensated by increase of the affected area, as at this point it was equal to the half of the nerve and could not increase further. These configurations were therefore discarded.
For the multi-electrode array, the inter-electrode circumferential distance was chosen on the basis of partial intersection of the activated areas and was equal to the electrode width, leading to 14 electrode pairs around the circumference of 2.8mm-diameter nerve. This was slightly adjusted together with the final electrode width due to manufacturing limitations (Figure 3 a) .
Multi-parametric minimisation of the combined costfunction (mean value between deep and superficial fibre) revealed the best parameters for symmetric longitudinal configuration. However, after considering the manufacturing constraints (accuracy of the laser cut and overall stability of the device) and real-life impedance values, another configuration was chosen which was in top 1% but had longer electrode length (Table 2) .
Complex pattern optimisation.
The optimal bipolar longitudinal configuration evaluation was followed by the proof of hypothesis that this configuration is optimal among any geometric electrode configurations. Since the problem is symmetric, one of the electrodes was fixed in its optimal state, whilst the second was changed with simultaneous objective function calculation (Figure 5.a) . The multi-electrode configurations can then be described as a linear combination of the above, and it can be shown that the cost function value was at least higher for any multi-electrode configuration. As an illustration, several typical configurations were tested ( Figure 5 .b) to confirm the result. Figure 4 . Summary of simulation results with bipolar longitudinal electrode configuration. In each simulation configuration, the minimal current activating desired virtual fascicle (deep or superficial) was identified, and then other parameters were analysed for this particular current: a) Schematics of the simulation with parameters. b) Examples of the electrode configurations used in simulations. c) The shapes of the activating function extracted from the simulations and applied as a boundary conditions to a 1D model of the axon. e) Maps of axonal activation were produced following the threshold of activation iterative computation for superficial (left) and deep (right) fibres. e) Threshold of activation variation with distance between the electrodes for the shortest (0.5mm) electrodes. f) Objective cost function dependence on the length of the electrode for deep (green) and superficial (blue) fibre. e) The Objective cost function vs. electrode width for deep (green), superficial (bue) fibre, and combined (red). 
In-vivo evaluation
Reproducible changes in both RR and HR in response to stimulation occurred in all 12 anaesthetised sheep (P<0.01, Figure 6 ). Sequential stimulation with increasing current was applied until a clear bradypnea response was observed in at least 1 pair of electrodes. The stimulation current was then adjusted to maintain the response (reduction in RR) restricted to 1-3 electrodes. This was 500  50 μA (N = 24 in 12 sheep). In this condition, a separate area evoking a cardiac response (reduction in HR) to stimulation could be identified in 9 out of 12 animals. In 3 out of 12 sheep, the HR did not change significantly during stimulation through any of the pairs tested. The RR was reduced by 85  5% with no change in HR (P > 0.5) when stimulating through the pair of electrodes evoking an optimal bradypnea response in all sheep. The HR was reduced by 20  7% with no change in RR (P > 0.5) when stimulating through the pair of electrodes evoking optimal cardiac response (N = 24 in 12 sheep).
Grouping all results together with rotational alignment by best respiratory-responsive site revealed significant spatial localisation of respiratory-and cardiac-responsive sites with respect to each other (P < 0.01, Figure 7 ) with an angular position of 105  5 degrees.
Discussion
Summary of results.
Optimisation of the electrode geometry in simulations allowed objective determination of parameters for selective neuromodulation of myelinated fibres in vagus nerve. The best current steering strategy with the biphasic square pulse is 2-electrode longitudinal with matched electrode pairs with respect to their radial position. The optimal electrode array had 14 longitudinal electrode pairs, located 3 mm apart. The optimal width was 0.4 mm, with the same inter-electrode circumferential distance, and length of 0.5 mm. The latter was found to not significantly alter the objective function and was replaced by 3 mm (with minimal penalty) due to contact impedance and manufacturability considerations.
The arrays were manufactured and tested in healthy anesthetised animals. For the first time a reliable reproducible selectivity in neuromodulation of respiration-specific and cardiac-specific fibres was demonstrated and confirmed. The experimental results also strongly suggest spatial organisation of organ-specific fibres in cervical vagus nerve even in large animals.
All the above suggests that cardiac-specifc and/or respiration-specific neuromodulation is possible without inadvertent stimulation of the other function. Also the result suggests the potential application of this therapy would be a refined VNS approach, by ensuring the avoidance of the majority of side effects associated with cardio-respiratoryvocal effects.
Study technical limitations and future work
Firstly, the study was limited to only consider bi-polar current source and bi-phasic symmetric current pulse. It was done on the basis of engineering practicality and reliability; however, authors admit that further investigations are required, and in fact 2-electrode longitudinal configuration might not be the best in case of non-symmetric current pulse. Secondly, study was only limited to myelinated fibres. This was done with the applicability to the existing trends in implantable stimulators and the particular diseases, however non-myelinated fibres are currently under investigation.
Future work will be concentrated on the further optimisation of the stimulation using fibre-specific and direction-specific stimulation paradigms with the view of delivering the ultimate device for spatial, directional and fibre selective therapeutic neuromodulation in complex nerves.
Finally, the use of a sheep as an animal model allowed using human-size vagus nerve as well as a model very often used for studying cardiac functions. However in the sheep the nerve may contain fibres innervating the rumen, which obviously is not human-related. It is therefore planned to validate the array in other large animal species such as pig. Figure 6 . 3 examples of the experimental results at optimal current levels. The stimulus pulse was delivered to the longitudinal electrode pair at each of 14 possible circumferential locations for 30s, followed by 30s interstimulationinterval. Some locations induced significant alterations in breathing pattern (apnoea), whilst the others caused significant bradycardia. 
Appendix 1
All of the equations and full description of the model can be found in [35] . 
